Ascendis Pharma A/S Financial Liabilities
Ascendis Pharma A/S (ASND) had Financial Liabilities of EUR 1.22 billion as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:FinancialLiabilities · last filed 2026-02-11
- 2025-12-31: Financial Liabilities 1.22B EUR.
- 2025-09-30: Financial Liabilities 1.13B EUR.
- 2025-06-30: Financial Liabilities 1.08B EUR.
- 2025-03-31: Financial Liabilities 1.11B EUR.
| Period end | Financial Liabilities |
|---|---|
| 2025-12-31 | 1.22B EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 1.13B EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 1.08B EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 1.11B EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 1.10B EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 1.03B EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 931.53M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 961.13M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 882.13M EUR 20-F · filed 2025-02-12 |
| 2023-03-31 | 753.59M EUR 6-K · filed 2023-04-27 |
| 2022-12-31 | 767.36M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 772.07M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 689.22M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 685.72M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 164.38M EUR 20-F · filed 2023-02-16 |
| 2020-12-31 | 113.87M EUR 20-F · filed 2022-03-02 |
| 2019-12-31 | 64.38M EUR 20-F · filed 2021-03-10 |